Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Cranial Implants Market, by Product Type
1.4.2 North America Cranial Implants Market, by Material
1.4.3 North America Cranial Implants Market, by End Use
1.4.4 North America Cranial Implants Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Cranial Implants Market by Product Type
3.1 North America Customized Cranial Implants Market by Country
3.2 North America Non-Customized Cranial Implants Market by Country
Chapter 4. North America Cranial Implants Market by Material
4.1 North America Metal Cranial Implants Market by Country
4.2 North America Ceramic Cranial Implants Market by Country
4.3 North America Polymer Cranial Implants Market by Country
Chapter 5. North America Cranial Implants Market by End Use
5.1 North America Neurosurgery Centers Market by Country
5.2 North America Hospital Market by Country
Chapter 6. North America Cranial Implants Market by Country
6.1 US Cranial Implants Market
6.1.1 US Cranial Implants Market by Product Type
6.1.2 US Cranial Implants Market by Material
6.1.3 US Cranial Implants Market by End Use
6.2 Canada Cranial Implants Market
6.2.1 Canada Cranial Implants Market by Product Type
6.2.2 Canada Cranial Implants Market by Material
6.2.3 Canada Cranial Implants Market by End Use
6.3 Mexico Cranial Implants Market
6.3.1 Mexico Cranial Implants Market by Product Type
6.3.2 Mexico Cranial Implants Market by Material
6.3.3 Mexico Cranial Implants Market by End Use
6.4 Rest of North America Cranial Implants Market
6.4.1 Rest of North America Cranial Implants Market by Product Type
6.4.2 Rest of North America Cranial Implants Market by Material
6.4.3 Rest of North America Cranial Implants Market by End Use
Chapter 7. Company Profiles
7.1 Zimmer Biomet Holdings, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Acquisition and mergers:
7.2 Johnson & Johnson (DePuy Synthes, Inc.)
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental &Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisition and mergers:
7.2.5.2 Collaborations, partnerships and agreements:
7.3 Stryker Corporation
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Acquisition and mergers:
7.3.5.2 Collaborations, partnerships and agreements:
7.4 B. Braun Melsungen AG
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.5 Synimed Sarl
7.5.1 Company Overview
7.6 Evonos GmbH & Co. KG
7.6.1 Company Overview
7.7 Medartis AG
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Acquisition and mergers:
7.8 Renishaw PLC
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.9 Kelyniam Global, Inc.
7.9.1 Company Overview
7.9.2 Recent strategies and developments:
7.9.2.1 Collaborations, partnerships and agreements:
7.9.2.2 Approval:
7.1 Medtronic PLC
7.10.1 Company overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expenses
7.10.5 Recent strategies and developments:
7.10.5.1 Acquisition and mergers:
Unique Offerings 